NCT06297343 Study of the Risk of Ischaemia Following the Creation of an Arteriovenous Fistula
| NCT ID | NCT06297343 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
| Condition | Renal Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 544 participants |
| Start Date | 2025-10-20 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 544 participants in total. It began in 2025-10-20 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to identify functional vascular changes and clinical factors correlated with the occurrence of short- or medium-term hand ischaemia after arteriovenous fistula creation.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years; * Stage 5 chronic kidney disease, on dialysis or not on dialysis; * Requiring the creation of an arteriovenous fistula; * Membership of a social insurance scheme; * Patient having been informed and having formulated his/her oral non-opposition to participate in the research. Exclusion Criteria: * Contraindication to the proposed surgery ; * Reduced life expectancy in the opinion of the investigator; * Medical or biological conditions which, in the opinion of the investigator, could influence the interpretation of the results of the study or the safety of the patient; * Patient uncooperative with protocol requirements or unable to attend scheduled visits to the centre; * Other surgical or medical intervention planned during the study; * Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding; * Participating in another clinical trial, or in a period of exclusion from another clinical trial; * Patient under guardianship or deprived of liberty.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06297343 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Renal Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06297343 currently recruiting?
Yes, NCT06297343 is actively recruiting participants. Contact the research team at v.duedal@gmail.com for enrollment information.
Where is the NCT06297343 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06297343 clinical trial?
NCT06297343 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 544 participants.